1561 unknown. 1561 Phase 3, 303 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1561 | Unknown 1561 |
| Phase 2 | 303 | Unknown 303 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS) Metformin, Semaglutide Injectable Product - Polycystic Ovary Syndrome | Phase 2 / Phase 3 | Unknown | University of Hull | 60 | 2025-03-01 | 2024-05-10 |
| Does Perioperative Intravenous Magnesium Affect Postoperative Quality of Recovery in Craniotomy Surgery Patients? IV magnesium sulfate, Placebo - Brain Tumor, Surgery | Phase 3 | Unknown | Thomas Jefferson University | 110 | 2024-11-01 | 2023-04-12 |
| Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer Fluzoparib, Apatinib Mesylate - Epithelial Ovarian Cancer, Efficacy | Phase 3 | Unknown | Anhui Provincial Hospital | 51 | 2024-10-01 | 2024-08-06 |
| Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome Dapagliflozin, Metformin - Polycystic Ovary Syndrome | Phase 3 | Unknown | Future University in Egypt | 70 | 2024-09-02 | 2024-10-22 |
| Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis celecoxib monotherapy, celecoxib and metformin combination - Familial Adenomatous Polyposis | Phase 3 | Unknown | Yonsei University | 28 | 2024-08-13 | 2024-08-09 |
| Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone - Hepatocellular Carcinoma | Phase 3 | Unknown | Guangxi Medical University | 300 | 2024-07-01 | 2024-01-23 |
| PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. Intestinal bacteria freeze-dried powder capsules - Nasopharyngeal Carcinoma | Phase 3 | Unknown | Yun-fei Xia | 96 | 2024-07-01 | 2024-07-03 |
| Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients Myoinositol, Chromium, l-arginine - Polycystic Ovary Syndrome | Phase 3 | Unknown | Beni-Suef University | 100 | 2024-06-30 | 2024-05-08 |
| Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage Enzalutamide 40 MG, Docetaxel injection - Prostate Cancer, Castrate Resistant Prostate Cancer | Phase 2 / Phase 3 | Unknown | Zhongnan Hospital | 120 | 2024-06-01 | 2024-02-28 |
| Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial Alpha-ketoglutarate, Placebo, Standard care - Colorectal Cancer | Phase 3 | Unknown | National University Hospital, Singapore | 80 | 2024-05-09 | 2024-10-17 |
| The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma Nelarabine injection - T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 83 | 2024-05-01 | 2024-05-30 |
| Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy Misoprostol 200mcg Tab, Oxytocin - Myoma;Uterus | Phase 3 | Unknown | Cairo University | 56 | 2024-03-01 | 2024-03-22 |
| Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult DEC3-VEN - Acute Myeloid Leukemia, Adult | Phase 2 / Phase 3 | Unknown | The Second Affiliated Hospital of Kunming Medical University | 40 | 2024-03-01 | 2024-02-29 |
| Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma Dabrafenib - Ameloblastoma | Phase 3 | Unknown | Shandong University | 10 | 2024-03-01 | 2024-02-20 |
| Proactive Management of Endoperitoneal Spread in Colonic Cancer Standard surgical treatment, Proactive management, Standard adjuvant systemic chemotherapy - Colon Cancer, Intraperitoneal Rectal Cancer | Phase 3 | Unknown | University of Roma La Sapienza | 140 | 2024-03-01 | 2023-05-06 |
| A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer SHR-1921, carboplatin, platinum-based doublet chemotherapy - Ovarian Cancer | Phase 2 / Phase 3 | Unknown | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 520 | 2024-02-15 | 2024-01-18 |
| Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation Adjuvant tislelizumab plus lenvatinib, Adjuvant tislelizumab - Hepatocellular Carcinoma, Recurrence | Phase 3 | Unknown | Guangxi Medical University | 200 | 2024-02-15 | 2024-01-23 |
| Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection sintilimab - Esophageal Squamous Cell Carcinoma Thoracic Stage II, Esophageal Squamous Cell Carcinoma Thoracic Stage III | Phase 3 | Unknown | Fujian Medical University Union Hospital | 400 | 2024-01-10 | 2023-12-08 |
| Optimising Patient Experience in Head and Neck Radiotherapy Conventional 5 point closed face immobilisation mask., 5 point open face immobilization mask, 3 point open face immobilization mask - Head and Neck Cancer | Phase 3 | Unknown | Irish Research Radiation Oncology Group | 201 | 2024-01-02 | 2024-03-25 |
| A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia Liposomal cytarabine-daunorubicin for injection, 7+3 (cytarabine and daunorubicin) - High-risk (Secondary) Acute Myeloid Leukemia | Phase 3 | Unknown | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 120 | 2024-01-01 | 2023-12-28 |
Showing 20 of 1561. Sign in to see all of them.
Breast Neoplasms (180) · Colorectal Neoplasms (117) · Carcinoma, Non-Small-Cell Lung (114) · Carcinoma, Hepatocellular (98) · Stomach Neoplasms (82) · Rectal Neoplasms (65) · Lung Neoplasms (56) · Colonic Neoplasms (54) · Leukemia, Myeloid, Acute (52) · Prostatic Neoplasms (52) · Nasopharyngeal Carcinoma (46) · Lymphoma, Large B-Cell, Diffuse (42) · Neoplasm Metastasis (41) · Uterine Cervical Neoplasms (41)
Neoplasms by Site (1162) · Neoplasms by Histologic Type (622) · Digestive System Diseases (481) · Digestive System Neoplasms (471) · Gastrointestinal Diseases (329) · Gastrointestinal Neoplasms (321) · Neoplasms, Glandular and Epithelial (298) · Hemic and Lymphatic Diseases (265) · Carcinoma (244) · Skin and Connective Tissue Diseases (222) · Pathological Conditions, Signs and Symptoms (215) · Skin Diseases (214) · Urogenital Diseases (206) · Intestinal Diseases (190)
Cisplatin (134) · Radiotherapy (101) · Cyclophosphamide (86) · Fluorouracil (84) · Capecitabine (77) · Gemcitabine (76) · Carboplatin (74) · Docetaxel (74) · Paclitaxel (71) · Oxaliplatin (68) · Doxorubicin (63) · Etoposide (58) · Vincristine (51) · Leucovorin (48) · Drug Therapy (46)
Sun Yat-sen University (91) · Fudan University (53) · Nanfang Hospital, Southern Medical University (21) · Chinese Academy of Medical Sciences (20) · European Organisation for Research and Treatment of Cancer - EORTC (20) · Samsung Medical Center (16) · Assistance Publique - Hôpitaux de Paris (15) · Tianjin Medical University Cancer Institute and Hospital (15) · Guangxi Medical University (14) · Medical Research Council (14) · Peking Union Medical College Hospital (14) · Zhejiang Cancer Hospital (14) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (13) · Ruijin Hospital (13) · Jiangsu HengRui Medicine Co., Ltd. (11)
China (625) · United Kingdom (128) · Italy (106) · France (98) · Germany (85) · United States (82) · Netherlands (70) · South Korea (70) · Canada (58) · Egypt (45) · Belgium (41) · Spain (36) · Taiwan (34) · Poland (33) · India (32)
Ming Shi, MD (6) · Qifa Liu (6) · Francesco Perrone, M.D., Ph.D. (5) · Ciro Gallo, M.D., Ph.D. (4) · Fernando Dimeo, MD (4) · Francesco Perrone, M.D., Ph.D (4) · Jia Fan, MD (4) · Lei Li, M.D. (4) · Sabino De Placido, MD (4) · Shegan Gao, Doctor (4) · Tanyou Shan, Master (4) · Xiaozhi Yuan, Master (4) · Aimery de Gramont, MD (3) · Alexander M. M. Eggermont, MD, PhD (3) · Andrey S. Bryukhovetskiy, MD (3)
PMID 37185961, PMID 12049862, PMID 25303679, PMID 25789053, PMID 34037241, PMID 38979716, PMID 11001674, PMID 11807147, PMID 11981766, PMID 12091661, PMID 12540794, PMID 15812540, PMID 20032498, PMID 20567002, PMID 20718753, PMID 21195303, PMID 22895629, PMID 23148692, PMID 23599758, PMID 24224128, PMID 24371038, PMID 24687837, PMID 25023199, PMID 25077927, PMID 25559415, PMID 25753432, PMID 26805559, PMID 27223606, PMID 27266524, PMID 27742014, PMID 29926156, PMID 30523055, PMID 32691060, PMID 33242441, PMID 36306483, PMID 39438442, PMID 40135712, PMID 40421698, PMID 41252656, PMID 41379261, PMID 41791006, PMID 10207464, PMID 10215657, PMID 10400410, PMID 10402169, PMID 10451482, PMID 10463285, PMID 10506634, PMID 10640954, PMID 10655437
2015 (7), 2014 (6), 2016 (6), 2005 (5), 2008 (5), 2009 (5), 2018 (3), 2019 (2), U10CA027469 (2), U10CA031946 (2), U10CA180868 (2), 2017 (1), P30CA016042 (1), R44CA256984 (1), U10CA012027 (1)